{ "items": [ "\n\n
\n \n 21 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n COPCOV\n \n \n \n \n COVID-19\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nA global study to test if either chloroquine or hydroxychloroquine can prevent COVID-19 in vital frontline healthcare workers will open to UK participants at hospital sites in Brighton and Oxford today.
\n \n\n\n \n 1 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nThe SEBCOV study aims to produce evidence to inform public health measures such as communications, quarantine, self-isolation, social distancing, and travel restrictions for the COVID-19 pandemic. This study is run in four countries: UK, Thailand, Italy and Malaysia.
\n \n\n\n \n 29 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Epidemiology Department of MORU and National Malaria Control Programme, Cambodia (CNM) have begun to implement a study to assess the efficacy of prophylaxis with artemether-lumefantrine (PAL) against forest malaria in Siem Pang District, north-eastern Cambodia bordering Laos.
\n \n\n\n \n 24 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nThe impact of COVID-19 is quite evident at present \u2013 entire countries and cities are under lockdown, offices and industries shut and academia at a standstill. However, many people in Bangladesh remain unaware or indifferent to the warnings and safety protocols that ought to be followed to stop COVID-19\u2019s spread. Since enforcing social distancing in a densely populated country like Bangladesh is very challenging, making people aware and maintenance of hygiene are the main means to stop the spread of COVID-19.
\n \n\n\n \n 23 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n COMRU\n \n \n \n \n COPCOV\n \n \n \n \n COVID-19\n \n \n \n \n LOMWRU\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nLess than a month after it was announced, the MORU-led COPCOV study has made quick progress and expects to begin enrolling participants by the end of April.
\n \n\n\n \n 10 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n LOMWRU\n \n \n\n \n\n\n
\n \n\n \n \n \nGlobal health experts have united in a call for governments and international organisations around the world to plan strategically for the coordinated production, equitable distribution and surveillance of COVID-19 medical products to ensure access to quality-assured medications for everyone.
\n \n\n\n \n 6 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n COPCOV\n \n \n \n \n COVID-19\n \n \n \n \n MORU Bangkok\n \n \n \n \n Public Engagement\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n \n \nThere are currently no proven vaccines or drugs to prevent COVID-19. In this BBC World News interview, MORU\u2019s Prof Sir Nick White explains why the only way to find out if chloroquine and hydroxychloriquine work against COVID-19 is via randomised, clinical trials and how the hype over chloroquine negatively affects people with lupus and rheumatoid arthritis.
\n \n\n\n \n 30 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n COPCOV\n \n \n \n \n COVID-19\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at MORU and two institutions in the US (University of Washington and La Jolla Institute for Immunology) receive grants from the COVID-19 Therapeutics Accelerator, a large-scale initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed the development of and access to therapies for COVID-19.
\n \n\n\n \n 11 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nAdding a third anti-malaria drug to current artemisinin-combination therapies (ACTs) provides effective treatment against multidrug-resistant falciparum malaria in Southeast Asia, say Oxford researchers in a study in The Lancet. Using TACTs should extend current malaria drugs so drug-resistant malaria doesn't kill millions more and derail hopes of controlling and eliminating malaria.
\n \n\n\n \n 6 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nFrom The Lancet Correspondence. In the opening to the 2019 World Malaria Report, entitled Leaving no one behind in the march to a malaria free world, the WHO\u2019s Director-General notes that the scourge of malaria continues to strike hardest against pregnant women and children in Africa.
\n \n\n\n \n 11 February 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nThe International Day of Women and Girls in Science recognises and celebrates the critical role played by women but also aims to promote their full and equal access to participation in science. However, despite more women than ever working across the sciences, it is still a male-dominated field with only 30% of female researchers, according to UNESCO. IDDO asked colleagues across their networks for their views. How we could encourage more women into science? And what changes are needed in order to keep them in science?
\n \n\n\n \n 10 January 2020\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nWhen we are ill, we expect our medicines to work as intended. But what if they do not contain the ingredients listed on the packaging? The Pharmacide Arts exhibition \u201cWhat\u2019s in your medicines?\u201d showcases the original artwork of 11 South East Asian artists. The exhibition is open to the public from 26th-28th January 2020 at the Mandarin Hotel, Bangkok, from 10 am \u2013 5 pm.
\n \n\n\n \n 23 December 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study conducted by Christiane Dolecek and colleagues analysed data on antimicrobial resistance of the bacteria Salmonella Typhi and Salmonella Paratyphi, from around the globe, spanning the time from 1990 to 2018. The study highlights the impact of drug resistance and the urgent need for interventions.
\n \n\n\n \n 22 November 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Joel Tarning received a Bailey K. Ashford Medal at the ASTMH 2019 Conference. The medal is awarded annually for distinguished work in tropical medicine by an early- to mid-career ASMTH member. Joel is Head of Clinical Pharmacology at MORU and his work focuses on applying pharmacokinetic-phamacodynamic modelling to optimise antimalarial drug therapies, in particular for at-risk groups such as malnourished children and pregnant women.
\n \n\n\n \n 19 November 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University has been ranked as the world's best institution for medical and health teaching and research for the ninth consecutive year in the latest Times Higher Education World University Rankings. The ranking is based on criteria measuring teaching, research, industry income, international outlook and citations, which are combined to provide a comparison of universities worldwide.
\n \n\n\n \n 7 November 2019\n \n
\n\n \n\n \n\n \n \n \n \n LOMWRU\n \n \n\n \n\n\n
\n \n\n \n \n \nNoting that substandard and falsified medical products (including medicines, vaccines, biologics, and diagnostics) represent a significant and growing threat to human health, The Lancet Global Health published 'The Global access to quality-assured medical products: the Oxford Statement and call to action'.
\n \n\n\n \n 16 October 2019\n \n
\n\n \n\n \n\n \n \n \n \n LOMWRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nWhen we are ill, we trust that the medicines that we take will make us feel and be better. But what if our pills do not contain the ingredients listed on the packaging? The art exhibition \u2018What\u2019s in your medicines?\u2019 explores how substandard and falsified (\u2018fake\u2019) medicines can affect our health, by showcasing the striking and original artwork of 12 South East Asian artists.
\n \n\n\n \n 9 October 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford Medical Sciences Divisional Panel has conferred the title of Professor on three members of our Centre. Ben Cooper - Professor of Epidemiology, Sassy Molyneux - Professor of Global Health and Piero Olliaro - Professor of Poverty Related Infectious Diseases were awarded these titles in recognition of their distinction in their respective fields and contributions to the research, teaching and administration of the Department and we congratulate them on their success!
\n \n\n\n \n 8 October 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nAn individual patient data meta-analysis of 2,017 patients from 19 studies has found a high risk of recurrence following treatment of P. vivax malaria with artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) unless they are co-administered with primaquine. The research supports recommendations that these artemisinin-based combination therapies (ACT) should be combined with primaquine.
\n \n\n\n \n 7 October 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Sir Peter J Ratcliffe, Director for the Target Discovery Institute within the Nuffield Department of Medicine at Oxford University and Director of Clinical Research at Francis Crick Institute, London, has today been announced as a winner of the Nobel Prize in Physiology or Medicine.
\n \n\n\n \n 18 September 2019\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n MORU Bangkok\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nMORU and SMRU were delighted and honoured to host the University of Oxford Vice-Chancellor Prof Louise Richardson and her party during her visit to Thailand on 1-4 September. Accompanying the Vice-Chancellor were Jeremy Woodall (Director of Development (Asia)), Frewyeni Kidane (Fundraiser for Southeast Asia), Cher Wu (Asia Development office) and Ed Gibbs (NDM Director of Finance and Operations).
\n \n\n\n \n 18 September 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nIn partnership with the Wellcome Innovations Flagship Programme, MORU launched its Critical Care Asia Network project with its first investigators\u2019 meeting on 19-20 Aug in Bangkok. The project will establish an Asian ICU network across 42 ICUs in nine countries and implement a setting-adapted electronic registry.
\n \n\n\n \n 17 September 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n General\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nTwo researchers from the Centre for Tropical Medicine and Global Health were awarded medals by the Royal Society of Tropical Medicine and Hygiene at the 2019 European Congress on Tropical Medicine and International Health. Professor David Warrell was awarded the Sir Patrick Manson Medal, and Dr Samson Kinyanjui the Chalmers Medal.
\n \n\n\n \n 11 September 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford has been named the world\u2019s number one university for the fourth successive year in the Times Higher Education World University Rankings.
\n \n\n\n \n 24 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nMORU researchers have found that severe malnutrition is associated with lower exposure to the antimalarial drug lumefantrine in children treated with artemether-lumefantrine, the most common treatment for uncomplicated falciparum malaria. The study, which is the first to specifically address this, calls urgently for further research into optimised dosing regimens for undernourished children.
\n \n\n\n \n 23 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nA rapidly evolving multi-drug resistant lineage of P. falciparum malaria parasites continues to spread in South East Asia, leading to alarmingly high treatment failure rates in Cambodia, Thailand and Vietnam for DHA-piperaquine, one of the world\u2019s most important anti-malaria drugs.
\n \n\n\n \n 19 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nA large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated and just as effective as the current standard 14 day regimen, according to a study published this week in The Lancet. These findings have important implications for the treatment and elimination of vivax malaria in the Asia Pacific.
\n \n\n\n \n 17 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n MOCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nMedical Action Myanmar and MOCRU health teams identified a number of children with rickets in remote areas of Myanmar. MOCRU director Frank Smithuis presented the findings of clinical screening to the Minister of Health, alongside treatment results and a plan for a large survey to investigate the prevalence of vitamin D deficiency and its underlying causes.
\n \n\n\n \n 10 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n Conferences & meetings\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nA project using drama that engages with village communities in Cambodia, led by Professor Phaik Yeong Cheah of the Mahidol Oxford Tropical Medicine Research Unit and Nuffield Department of Medicine, has won a Project award in this year\u2019s Vice-Chancellor\u2019s Public Engagement with Research Awards. The project also won the Vice-Chancellor\u2019s Choice Award for Public Engagement with Research.
\n \n\n\n \n 2 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research by Makoto Saito and colleagues at SMRU found that a longer follow-up is required to assess antimalarial drug efficacy in pregnant women. This was found across all drugs assessed in low malaria transmission settings. The report\u2019s authors have called for guidelines specifically for pregnant women and further investigation of optimal follow-up periods in high malaria transmission settings.
\n \n\n\n \n 13 June 2019\n \n
\n\n \n\n \n\n \n \n \n \n MOCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nA ground-breaking study in Bangladesh co-lead by Mahidol Oxford Tropical Medicine Research Unit (MORU) has found that using data from mobile phone networks to track the movement of people across the country can help predict where outbreaks of diseases such as malaria are likely to occur, enabling health authorities to take preventative measures.
\n \n\n\n \n 4 June 2019\n \n
\n\n \n\n \n\n \n \n \n \n MOCRU\n \n \n \n \n Public Engagement\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nMORU, SMRU and FilmAid Foundation invite you to the Bangkok Premiere of Under the Mask on the 17th June. This drama film is based on real testimonies of TB patients. The story follows the lives of our characters as they journey from diagnosis to treatment and help from the SMRU TB team, and explores how each discovers their capacity to overcome the deadly disease and share their knowledge and experience with others. Made in the local language, this film provides an engaging and inspiring tool for raising TB awareness in the community.
\n \n\n\n \n 10 May 2019\n \n
\n\n \n\n \n\n \n \n \n \n MOCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThis year, the Pint of Science festival in Thailand is in not one but two cities! Join us in Bangkok at WeLearn on 21st-22nd May, and at Hungry Wolf's in Chiang Rai on 25th May.
\n \n\n\n \n 10 May 2019\n \n
\n\n \n\n \n\n \n \n \n \n MOCRU\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe 5th May is World Hand Hygiene Day. To raise awareness among staff and the Thai-Myanmar border populations of the importance of hand washing, a simple, proven effective way of infection prevention, the SMRU infection control committee worked with the SMRU clinics and Mae Sot lab staff to create this fantastic video.
\n \n\n\n \n 7 May 2019\n \n
\n\n \n\n \n\n \n \n \n \n MOCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nHow to change urban Myanmar communities' antibiotics usage habits? Check out 'Fever and Antibiotic Use', a Wellcome-funded community theatre initiative by MOCRU Research Coordinator Dr Myo Maung Maung Swe. Myo uses forum theatre to engage Yangon residents in a lively manner so they can learn when to use antibiotics \u2013 or not.
\n \n\n\n \n 3 May 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nThis 5-day course is aimed at participants with a basic understanding of infectious disease modelling and an aptitude for the R programming language. On completion participants will be able to write and analyse the dynamics of a simple mathematical model and use it to consider cost and intervention scenarios. September 23-27 at St Anne\u2019s College, Oxford
\n \n\n\n \n 30 April 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nTo mark World Malaria Day on 25 April WWARN\u2019s Dr Makoto Saito and Professor Joel Tarning from the Mahidol Oxford Tropical Medicine Research Unit and Head of WWARN Pharmacometrics presented their work on prevention and treatment of malaria in vulnerable groups at a seminar hosted by the Centre for Tropical Medicine and Global Health
\n \n\n\n \n 25 April 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nIncreased funding is needed to eliminate malaria across 22 Asia-Pacific countries and save an estimated 400,000 lives, according to research published in a new collection of studies on Wellcome Open Research.
\n \n\n\n \n 3 April 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nHow do you go about building all the skills you need at the start of your research career? Cherry Lim from our MORU unit in Bangkok, Thailand, was lucky to find a good mentor who guided her through this journey, but her own ceaseless curiosity and excitement about research were also important.
\n \n\n\n \n 26 March 2019\n \n
\n\n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n \n \nRob van der Pluijm presented encouraging findings from TRAC II trial analyses of Triple Artemisinin Combination Therapies to the All-Party Parliamentary Group on Malaria & NTDs on March 19th in Westminster at the Houses of Parliament.
\n \n\n